$3.07
-0.08-2.54%
Last update: Nov 11, 4:00 PM
Nephros Inc
NEPHNASDAQ
Nephros fell 29.1% from $4.33 to $3.07, behind the S&P 500's +9.8%. Its worst day was Mar 16 (−16.6%), and its low came Apr 7 at $2.78.
Nov 11, 2025 – Nov 11, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
Nephros shares rose 23.4%, while the S&P 500 fell 0.9%.
+23.4%, the year's best day · S&P 500 −0.9%
Nephros shares rose 16.8%, while the S&P 500 rose 0.9%.
+16.8% · S&P 500 +0.9%
Story events cover the past 12 months · Times ET
Nephros closed at its highest level of the year, 33.6% above where the year started.
+7.1% · S&P 500 +0.1%
EPS of $0.01 beat the $0.01 estimate on $4.7M revenue (est. $4.5M).
−7.9% · S&P 500 −0.6%
Nephros closed at its lowest level of the year, 35.8% below where the year started.
−2.8% · S&P 500 0.0%
EPS of $0.01 beat the $0.01 estimate on $5.2M revenue (est. $5.0M).
+9.0% · S&P 500 +0.8%
Nephros shares rose 17.6%, while the S&P 500 fell 0.1%.
+17.6% · S&P 500 −0.1%
EPS of $0.11 beat the $-0.01 estimate on $6.0M revenue (est. $5.1M).
+17.3% · S&P 500 +0.6%
Nephros shares fell 14.9%, while the S&P 500 rose 0.5%.
−14.9% · S&P 500 +0.5%
EPS of $0.05 beat the $0.03 estimate on $5.6M revenue (est. $5.4M).
−9.7% · S&P 500 +0.3%
Where it ended: a close of $3.07 on Nov 11, 2026. Up next: Q4 2026 earnings on Mar 11, 2027 (EPS est. $0.03, revenue est. $5.4M).
Nothing in the past 12 months.
All NEPH analyst actionsNothing in the past 12 months.
All NEPH dividend historyReplay the year: the line draws itself and stops at each of the 10 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for NEPH and SPY from Benzinga historical bars. Not investment advice.
